Publicaciones en las que colabora con JACQUES JM VAN DONGEN (15)

2017

  1. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    Leukemia, Vol. 31, Núm. 10, pp. 2094-2103

2012

  1. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation

    Leukemia, Vol. 26, Núm. 8, pp. 1821-1828

2011

  1. Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats

    Leukemia, Vol. 25, Núm. 9, pp. 1467-1470

2007

  1. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma

    Blood, Vol. 110, Núm. 9, pp. 3112-3121

2006

  1. TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells

    Leukemia, Vol. 20, Núm. 3, pp. 505-513

2004

  1. Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease - A study within the Europe against cancer program [9]

    Leukemia

2003

  1. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936

    Leukemia, Vol. 17, Núm. 12, pp. 2257-2317

  2. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: Immunobiological characteristics and clinical implications

    Leukemia, Vol. 17, Núm. 7, pp. 1398-1403

  3. Standardization and quality control studies of 'real time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program

    Leukemia, Vol. 17, Núm. 12, pp. 2318-2357

2001

  1. Immunoglobulin lambda isotype, gene rearrangements in B cell malignancies

    Leukemia, Vol. 15, Núm. 1, pp. 121-127

1999

  1. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705

  2. Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma

    Haematologica, Vol. 84, Núm. 4, pp. 328-335

  3. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies

    Haematologica, Vol. 84, Núm. 9, pp. 779-784

  4. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia

    Leukemia, Vol. 13, Núm. 1, pp. 110-118

  5. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia

    Leukemia